Lifecore Biomedical Inc (LFCR) Actualités

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational

Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials...

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference

CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the...

Form 8-K - Current report

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the...

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the...

Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the...

Form 4 - Statement of changes in beneficial ownership of securities

Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference

CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report